February was a strong month for FAST-ACT as our team continued supporting responder preparedness through hands-on demonstrations and international engagement. From a focused training in Kentucky to representation at a major European CBRN event, these activities reinforced the growing role of dry decontamination in modern chemical response.
On February 4, FAST-ACT conducted a dry decontamination training and demonstration in Frankfort, Kentucky with the state’s Emergency Preparedness and Response Branch. The 1.5-hour session combined classroom instruction with live, practical demonstrations to help attendees strengthen their understanding of dry decontamination in chemical and hazardous materials incidents.
The training focused on:
Core decontamination terminology used in CBRN and HAZMAT incidents
Field applications for dry decontamination in chemical scenarios
FAST-ACT technology, testing, and safety awareness
Proper use of FAST-ACT products in emergency situations
A key component of the day was the transition from presentation to live demonstration. Participants rotated through practical stations that included:
Sensitive equipment decontamination
Skin decontamination
Waterless personnel decontamination
Liquid spill containment
These hands-on segments allowed attendees to see how dry decontamination can be applied quickly when water-based methods are delayed, limited, or operationally challenging. The session emphasized real-world applicability and reinforced confidence in dry decontamination as part of a layered response strategy.

FAST-ACT also had a presence at CBRN Summit Europe in Lyon, France, represented by our official French distributor, SCOPEX. This event brought together CBRN and emergency response professionals from across the region to explore current technologies and response strategies.
At the summit, attendees were able to:
See FAST-ACT rapid-response chemical mitigation solutions and demonstrations
Speak with SCOPEX and FAST-ACT representatives about deployment and training considerations
Learn how FAST-ACT technology supports responder safety and faster on-scene mitigation
International engagement like this helps expand awareness of dry decontamination capabilities and supports cross-border knowledge sharing among response communities.

February’s activities reflect FAST-ACT’s ongoing commitment to preparedness, education, and practical capability building. Whether through state-level trainings or global CBRN events, the goal remains the same: helping responders act quickly, safely, and effectively during chemical incidents.
Organizations interested in hosting a FAST-ACT demonstration or training session can explore our Emergency Management Training Page to bring tailored dry decontamination education to their teams.
Timilon Corporation is the manufacturer of FAST-ACT®, a proprietary formulation of non-toxic high-performance specialty materials effective at neutralizing a wide range of toxic chemicals with the added capability to destroy chemical warfare agents. The FAST-ACT technology is utilized by leading defense agencies, chemical industrial companies, first responders and HAZMAT teams to quickly and safely eliminate chemical hazards. For more information, reach out to Leticia Menzzano, Marketing Manager, lmenzzano@timilon.com.
FAST-ACT is a dry decontamination technology designed to help neutralize and contain a broad range of chemical hazards, including toxic industrial chemicals (TICs), toxic industrial materials (TIMs), and certain chemical warfare agent threats. It is used to support safer, faster response during chemical incidents.
FAST-ACT products are used by a range of organizations, including: Fire and HAZMAT teams, Emergency management agencies, Healthcare and hospital preparedness teams, Military and specialized response units, Industrial safety and response teams
Organizations can contact FAST-ACT to discuss training goals, team size, and operational needs or visit our training page.
The FAST-ACT Decontamination Mitt and The FAST-ACT Decontamination Wipe are CE classified in the EU as Class I medical devices for use on skin and surfaces.
